Evidence map›Paper›PMID 37286766›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2023

Publisher Correction to: Trace amine-associated receptor 1 agonism promotes wakefulness without impairment of cognition in Cynomolgus macaques.

Anushka V Goonawardena, Stephen R Morairty, Ryan Dell, Gabriel A Orellana, Marius C Hoener, Tanya L Wallace, Thomas S Kilduff

Open access · bronzeAbstract readPublished Erratum
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Anushka V GoonawardenaCenter for Neuroscience, Biosciences Division, SRI International, Menlo Park, CA, 94025, USA.
Stephen R MorairtyCenter for Neuroscience, Biosciences Division, SRI International, Menlo Park, CA, 94025, USA.
Ryan DellCenter for Neuroscience, Biosciences Division, SRI International, Menlo Park, CA, 94025, USA.
Gabriel A OrellanaCenter for Neuroscience, Biosciences Division, SRI International, Menlo Park, CA, 94025, USA.
Marius C HoenerNeuroscience, Ophthalmology and Rare Disease DTA, pRED, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.ORCID http://orcid.org/0000-0001-6510-6250
Tanya L WallaceCenter for Neuroscience, Biosciences Division, SRI International, Menlo Park, CA, 94025, USA.
Thomas S KilduffCenter for Neuroscience, Biosciences Division, SRI International, Menlo Park, CA, 94025, USA. thomas.kilduff@sri.com.ORCID http://orcid.org/0000-0002-6823-0094
SRI International · USRoche (Switzerland) · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37286766
PMCPMC10354191
OpenAlexW4379653470

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.